Literature DB >> 24303857

Pre-operative co-morbidity and postoperative survival in the elderly: beyond one lunar orbit.

J B Carlisle1.   

Abstract

Mortality is a good measure of killing, but it is a poor measure of cure, palliation or the maintenance of function. Nevertheless, it has remained the primary metric of hospital care for 200 years. This article discusses the factors that contribute to mortality risk and survival trajectories, as well as the increasing recognition that surgery kills for months after the last suture is tied. This article discusses how disparate factors can usefully combine to generate an 'elderly' group with a monthly mortality in excess of 1% and a median life expectancy less than 3.5 years. A downloadable spreadsheet is provided that combines risk factors to generate mortality risks and their associated survival curves, emphasising the importance of looking beyond one postoperative month.
© 2013 The Association of Anaesthetists of Great Britain and Ireland.

Mesh:

Year:  2014        PMID: 24303857     DOI: 10.1111/anae.12489

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

1.  What happens when we do not operate? Survival following conservative bowel cancer management.

Authors:  R Bethune; M Sbaih; C Brosnan; T Arulampalam
Journal:  Ann R Coll Surg Engl       Date:  2016-04-08       Impact factor: 1.891

2.  Transitions of care in the perioperative period - a review.

Authors:  Anne-Marie Bougeard; Beverley Watkins
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

3.  Improvement of perioperative care of the elderly patient (PeriAge): protocol of a controlled interventional feasibility study.

Authors:  Cynthia Olotu; Lisa Lebherz; Levente Kriston; Rainer Kiefmann; Martin Härter; Anna Mende; Lili Plümer; Alwin E Goetz; Christian Zöllner
Journal:  BMJ Open       Date:  2019-11-24       Impact factor: 2.692

4.  Morbidity after elective surgery in patients on chronic dialysis: a systematic review and meta-analysis.

Authors:  Dharmenaan Palamuthusingam; Arun Nadarajah; David Wayne Johnson; Elaine Marie Pascoe; Carmel Marie Hawley; Magid Fahim
Journal:  BMC Nephrol       Date:  2021-03-18       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.